Alpha-1 Antitrypsin Drugs Market
Alpha-1 Antitrypsin Drugs Global Strategic Research Report 2024: Advances in Biomarker Identification Generate New Opportunities for Targeted Therapies - Forecast to 2030
20 sept. 2024 09h24 HE | Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
22157.jpg
Chronic Obstructive Pulmonary Disease (COPD) Epidemiology Forecast to 2033: Focus on US, France, Germany, Italy, Spain, UK, and Japan
13 sept. 2024 06h56 HE | Research and Markets
Dublin, Sept. 13, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. In the...
Chronic Obstructive Pulmonary Disease (COPD) Market
Chronic Obstructive Pulmonary Disease (COPD) Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Pfizer, GSK, Novartis, Astellas, Abbott, Boehringer Ingelheim, Almirall
10 sept. 2024 05h12 HE | Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis,...
22157.jpg
Respiratory Drugs - Market Insights, Competitive Landscape, and Industry Forecast to 2030; Featuring Company and Product Profiles of AstraZeneca, F. Hoffmann-La Roche, Teva Pharma, Novartis, GSK, and More
29 août 2024 05h37 HE | Research and Markets
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Drugs - Market Insights, Competitive Landscape, and Industry Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's...
Logo.png
Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight
07 août 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight The growing global prevalence of...
Acute Respiratory Distress Syndrome Market
Acute Respiratory Distress Syndrome Analysis Report 2024: A $2.36 Billion Market by 2032 from $1.23 Billion in 2023
18 juil. 2024 06h27 HE | Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome Market Report by Type, End User, Regions and Company Analysis 2024-2032" report has been added to ...
22157.jpg
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Report 2024: Comprehensive Insights About 65+ Companies and 70+ Pipeline Drugs
17 juil. 2024 09h07 HE | Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
22157.jpg
United States Pulmonary/Respiratory Diseases KOLs Fair-Market Value Compensation Rates Report: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs)
10 juil. 2024 05h29 HE | Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The " Fair-Market Value Compensation Rates for Pulmonary/Respiratory Diseases KOLs - United States" report has been added to ResearchAndMarkets.com's...
Global Non-Cystic Fibrosis Bronchiectasis Market
$4.8 Bn Non-Cystic Fibrosis Bronchiectasis Market - Global Industry Size, Share, Trends, Opportunity and Forecasts, 2019-2029F
05 juil. 2024 10h23 HE | Research and Markets
Dublin, July 05, 2024 (GLOBE NEWSWIRE) -- The "Non-Cystic Fibrosis Bronchiectasis Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F" report has been added to ...
Chronic Refractory Cough Market
Major Chronic Refractory Cough Markets: Epidemiology, Trends, Opportunities, and Forecast 2024-2034
28 juin 2024 10h25 HE | Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Chronic Refractory Cough Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...